Altman, however, isn't following any treatment or therapies from the startup he has funded since it is still in the research phase.Many might know Altman from his days at Y Combinator, where he put his money into early-stage startups such as Pinterest, Airbnb, Stripe, and many others during the Web 2.0 era. However, he moved away from startup investing and assumed the position of CEO at OpenAI, a company he co-founded in 2015.
Altman first got interested in anti-aging biotech during his time Y-Combinator when he came across experiments where older mice were rejuvenated by using blood from younger mice and were keen to fund startups in this space. Altman contacted Betts LaCroix, once a part-time biotech partner at Y-Combinator, and asked him if we could lead a company that worked on anti-aging projects. When LaCroix agreed, Retro Biosciences was born with $180 million in funding from Altman.The company workspace was quickly set up by placing prefab shipping containers outfitted as laboratories into a warehouse, allowing work to be carried out at a brisk pace, and the company has some preliminary results to showcase already.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IntEngineering - 🏆 287. / 63 Read more »